cancer and actinic damage皮肤癌和皮肤光化性损伤课件_第1页
cancer and actinic damage皮肤癌和皮肤光化性损伤课件_第2页
cancer and actinic damage皮肤癌和皮肤光化性损伤课件_第3页
cancer and actinic damage皮肤癌和皮肤光化性损伤课件_第4页
cancer and actinic damage皮肤癌和皮肤光化性损伤课件_第5页
已阅读5页,还剩35页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

Diagnosis of skin lesions and treatment of actinic damage Dr Philip Hampton RVI Aims Melanoma and pigmented lesions Clinical features Non melanoma skin cancer Clinical features BCC SCC Actinic damage Clinical features Diagnosis and management Pigmented lesions Melanocytic Lentigo Simplex Maligna Naevi Junctional, compound, intradermal Melanoma Non-melanocytic pigmented lesions Seborrhoeic warts Dermatofibroma (BCC) Assessment of pigmented lesions History Change Bleeding Clinical Asymmetry Borderline Colour Diameter Dermatoscopy Significance of clinical signs Major features Change in size of lesion Irregular pigmentation Irregular border Minor features Inflammation Itch/altered sensation Lesion larger than others Oozing/crusting Lentigo Lentigo Pigmented macule Normally sun exposed Increased melanocytes Growth within basal layer of epidermis Lentigo simplex Lentigo maligna (freckle increased melanin, normal melanocyte number) Melanoma Sun exposure ( not acral MM) Worse prognosis Head and neck ulceration Thicker Breslow Breslow ThicknessApproximate 5 year survival 4 mm50% Assessment Clinical Asymmetry Borderline Colour Diameter Referral details Melanoma screening clinic 2WW choose and book 80-140 per week On average 4 MM per week Basal cell skin cancer Most common cancer Incidence increasing High risk / low risk Numerous clinicalsubtypes Nodular Superficial Morphoeic Pigmented BCC: diagnosis Types of BCC Nodular Cystic Morphoeic Superficial Pigmented BCC- morphoeic Scar like Ill defined edges Risk of recurrence MOHS surgery recommended if critical site BCC referrals Choose and book New Monday afternoon BCC clinic from August Aim to see all BCCs within 4 weeks If on eyelids or nose Dermatology Surgery Written referral preferable Some patients directed to the joint dermatology surgery and occuloplastic clinic Keratinocyte dysplasia Actinic damage Actinic keratosis Hypertrophic actinic keratosis Bowens disease Bowenoid actinic keratosis Keratoacanthoma Squamous cell carcinoma Differentiation status: well, moderate, poor KERATIN HORN Actinic damage Keratinocyte dysplasia Epidermis only Variable extent Actinic Keratoses Bowens disease Intra epithelial dysplasia Full thickness of epidermis dysplastic Keratoacanthoma An SCC Very well differentiated May spontaneously regress Squamous cell carcinoma Chance of recurrence Site Head and neck Lips, ear Differentiation state Well, moderate, poor Invasion of skin structures Vessels, nerves, lymphatics Immunosuppression Recurrent lesion Actinic damage: When to treat in the clinic Diagnosis- must be made Epidermal proliferation/ Lesion thickness AK or SCC- can be hard to tell clinically Thickness of scale Any erosion Location Lips- high risk -always refer Lower legs-often poor response AKs: When to treat Malignant transformation of solar keratoses to squamous cell carcinoma. Marks R et al Lancet 1988 1689 people (40yrs), 21,905 AKs, over 5 years Transformation risk within one year less than 1 in 1000 Spontaneous remission of solar keratoses: the case for conservative management. Marks R et al Brit J Dermatol 1986 1040 people (40yrs) 224 (36.4%) had lesoins that spontaneously resolved SCC incidence 0.24% for each solar keratosis present Treatment Nothing, emollients, sun protection Liquid nitrogen Curettage and cautery Excision Topical Efudix Imiquimod (Solaraze) Solaraze Does it work? Diclofenac sodium 3% gel Trials have very short follow up 30days Int J Dermatol 2002 Complete clearance 47% vs 19% (placebo) Well tolerated 5-flurouracil- Effudix Inhibition of thymidylate synthase Interference with pyrimidine synthesis Apoptosis of rapidly dividing cells Patient education is crucial Appropriate review appointments Imiquimod 5% cream Immune response modifier Binds Toll like receptor 7 (TLR-7) Increased INF, IL-6, TNF Activation of immune system Innate adaptive Apoptosis Potential problems of topical treatment Inflammation Education Patient expectations Infection Polyfax ointment antibiotics Treatment failure Compliance ? Wrong diagnosis SCC and AK referrals SCC 2 week wait SCC clinic Faxed referrals to RVI AK GP treatment South of Tyne Community Dermatology service Routine choose and book referral to RVI. Summary Pigmented le

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论